Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 18, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytokinetics Inc
| 4.08K |
—
|
—
| +15.94% | 29.66K | +1 |
Mar 14
| ||||||
Cytokinetics Inc
| -2.64K |
$67.42 | -$177,989.60 | -9.35% | 25.59K | +1 |
Mar 4 - Mar 6
| ||||||
Cytokinetics Inc
| 6K |
—
|
—
| +27.76% | 27.61K | +1 |
Mar 6
| ||||||
Cytokinetics Inc
| -692.00 |
$39.13 | -$27,077.96 | -3.10% | 21.61K | +1 |
Mar 6
| ||||||
Cytokinetics Inc
| -2.48K |
$39.60 | -$98,366.40 | -10.02% | 22.3K | +1 |
Mar 2
| ||||||
Cytokinetics Inc
| -2.23K |
$45.21 | -$100,999.14 | -8.27% | 24.79K | +1 |
Feb 21
|
Scheduled
| |||||
Cytokinetics Inc
| -510.00 |
$44.13 | -$22,506.30 | -1.85% | 27.02K | +1 |
Feb 16
| ||||||
Cytokinetics Inc
| -3.00K |
$45.00 | -$135,180.00 | -9.84% | 27.53K | +1 |
Feb 3
|
Scheduled
| |||||
Cytokinetics Inc
| -2.10K |
$40.68 | -$85,428.00 | -6.43% | 30.54K | +1 |
Nov 14
| ||||||
Cytokinetics Inc
| -1.38K |
$36.83 | -$50,972.72 | -4.15% | 31.96K | +1 |
Mar 7
| ||||||
Cytokinetics Inc
| 6.05K |
$37.63 | -$54,450.61 | +22.18% | 33.34K | +1 |
Mar 2
| ||||||
Cytokinetics Inc
| 1.99K |
—
|
—
| +7.85% | 27.29K | +1 |
Feb 16
| ||||||
Cytokinetics Inc
| -1.36K |
$19.19 | -$26,079.21 | -5.38% | 23.88K | +1 |
Mar 8
| ||||||
Cytokinetics Inc
| 10K |
—
|
—
| +65.63% | 25.24K | +1 |
Mar 2
| ||||||
Cytokinetics Inc
| 10K |
—
|
—
| +332.89% | 13K | +1 |
Mar 6
| ||||||
Cytokinetics Inc
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||